同音
发表于 2025-3-23 11:54:46
http://reply.papertrans.cn/59/5826/582588/582588_11.png
IOTA
发表于 2025-3-23 16:01:17
http://reply.papertrans.cn/59/5826/582588/582588_12.png
制度
发表于 2025-3-23 18:00:51
n and observation than on evidence. The idea that coronary artery disease was an in?- matory problem in which the main culprit was oxidized LDL and the idea that heart disease risk could be managed had not yet 978-0-387-76605-8978-0-387-76606-5
MOT
发表于 2025-3-24 02:14:02
http://reply.papertrans.cn/59/5826/582588/582588_14.png
Coronation
发表于 2025-3-24 03:07:01
David Guerineauithmand its limitations and advantages in assessing CVD risk. The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting thes978-1-60327-501-9978-1-60327-502-6Series ISSN 2364-1150 Series E-ISSN 2364-1169
公司
发表于 2025-3-24 10:26:42
David Guerineauithmand its limitations and advantages in assessing CVD risk. The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting thes978-1-60327-501-9978-1-60327-502-6Series ISSN 2364-1150 Series E-ISSN 2364-1169
connoisseur
发表于 2025-3-24 12:31:19
http://reply.papertrans.cn/59/5826/582588/582588_17.png
开始发作
发表于 2025-3-24 17:11:31
http://reply.papertrans.cn/59/5826/582588/582588_18.png
乞讨
发表于 2025-3-24 22:06:19
David Guerineauithmand its limitations and advantages in assessing CVD risk. The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting thes978-1-60327-501-9978-1-60327-502-6Series ISSN 2364-1150 Series E-ISSN 2364-1169
生命
发表于 2025-3-25 01:17:56
David Guerineauithmand its limitations and advantages in assessing CVD risk. The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting thes978-1-60327-501-9978-1-60327-502-6Series ISSN 2364-1150 Series E-ISSN 2364-1169